Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #091
2449
mi
from 98109
Southbridge, MA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #091
2449
mi
from 98109
Southbridge, MA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 6
1933
mi
from 98109
Chesterfield, MI
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 6
1933
mi
from 98109
Chesterfield, MI
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #011
1909
mi
from 98109
Novi, MI
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #011
1909
mi
from 98109
Novi, MI
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 48
1793
mi
from 98109
Wyoming, MI
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 48
1793
mi
from 98109
Wyoming, MI
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 31
1381
mi
from 98109
Plymouth, MN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 31
1381
mi
from 98109
Plymouth, MN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #021
1983
mi
from 98109
Jackson, MS
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #021
1983
mi
from 98109
Jackson, MS
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #019
1624
mi
from 98109
Mexico, MO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #019
1624
mi
from 98109
Mexico, MO
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 21
2392
mi
from 98109
Lebanon, NH
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 21
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #014
2378
mi
from 98109
Cedar Knolls, NJ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #014
2378
mi
from 98109
Cedar Knolls, NJ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #009
mi
from 98109
Egg Harbor Township, NJ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #009
mi
from 98109
Egg Harbor Township, NJ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #063
mi
from 98109
Ocean, NJ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #063
mi
from 98109
Ocean, NJ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #080
2129
mi
from 98109
Brooklyn, NY
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #080
2129
mi
from 98109
Brooklyn, NY
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 22
2411
mi
from 98109
Great Neck, NY
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 22
2411
mi
from 98109
Great Neck, NY
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #079
2161
mi
from 98109
Rochester, NY
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #079
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 043
mi
from 98109
Rockville Center, NY
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 043
mi
from 98109
Rockville Center, NY
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 087
2139
mi
from 98109
Stony Brook, NY
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 087
2139
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #013
2281
mi
from 98109
Charlotte, NC
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #013
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 41
2427
mi
from 98109
Greenville, NC
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 41
2427
mi
from 98109
Greenville, NC
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #058
2455
mi
from 98109
Wilmington, NC
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #058
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #069
2008
mi
from 98109
Columbus, OH
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #069
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #070
1959
mi
from 98109
Dayton, OH
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #070
1959
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #055
2032
mi
from 98109
Mentor, OH
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #055
2032
mi
from 98109
Mentor, OH
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #094
2011
mi
from 98109
Westlake, OH
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #094
2011
mi
from 98109
Westlake, OH
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #028
1558
mi
from 98109
Tulsa, OK
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #028
1558
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #030
2373
mi
from 98109
Philadelphia, PA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #030
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #034
2246
mi
from 98109
Sayre, PA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #034
2246
mi
from 98109
Sayre, PA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #045
2423
mi
from 98109
Charleston, SC
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #045
2423
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #084
1976
mi
from 98109
Franklin, TN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #084
1976
mi
from 98109
Franklin, TN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #020
1952
mi
from 98109
Germantown, TN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #020
1952
mi
from 98109
Germantown, TN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #053
1970
mi
from 98109
Nashville, TN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #053
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #074
1857
mi
from 98109
Union City, TN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #074
1857
mi
from 98109
Union City, TN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 101
1645
mi
from 98109
Denton, TX
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 101
1645
mi
from 98109
Denton, TX
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #071
1673
mi
from 98109
Plano, TX
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #071
1673
mi
from 98109
Plano, TX
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 47
1787
mi
from 98109
San Antonio, TX
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 47
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #082
1887
mi
from 98109
Sugar Land, TX
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #082
1887
mi
from 98109
Sugar Land, TX
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #012
675
mi
from 98109
Ogden, UT
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #012
675
mi
from 98109
Ogden, UT
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #040
2
mi
from 98109
Seattle, WA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #040
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated:  9/28/2010
Veterans Affairs Medical Center
1506
mi
from 98109
Kansas City, MO
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated: 9/28/2010
Veterans Affairs Medical Center
1506
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated:  10/13/2010
Parkland Health and Hospital Systems
1682
mi
from 98109
Dallas, TX
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated: 10/13/2010
Parkland Health and Hospital Systems
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated:  10/13/2010
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated: 10/13/2010
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated:  10/13/2010
Scott & White
1743
mi
from 98109
Temple, TX
Therapeutic Stockings to Prevent Foot Ulcers
Therapeutic Stockings to Prevent Foot Ulcers
Status: Enrolling
Updated: 10/13/2010
Scott & White
1743
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Status: Enrolling
Updated:  10/15/2010
University of Nebraska Medial Center
1355
mi
from 98109
Omaha, NE
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Status: Enrolling
Updated: 10/15/2010
University of Nebraska Medial Center
1355
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/15/2010
University of Arizona
1220
mi
from 98109
Tucson, AZ
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/15/2010
University of Arizona
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/15/2010
Parkland Health and Hospital Systems
1682
mi
from 98109
Dallas, TX
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/15/2010
Parkland Health and Hospital Systems
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/15/2010
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/15/2010
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/15/2010
Scott & White
1743
mi
from 98109
Temple, TX
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/15/2010
Scott & White
1743
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated:  10/22/2010
San Francisco Center for Advanced Wound Care
687
mi
from 98109
Daly City, CA
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated: 10/22/2010
San Francisco Center for Advanced Wound Care
687
mi
from 98109
Daly City, CA
Click here to add this to my saved trials
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated:  10/22/2010
The SF Center For Advanced Wound Care At
687
mi
from 98109
Daly City, CA
Clinical Evaluation of the SNaP Wound Care System
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System
Status: Enrolling
Updated: 10/22/2010
The SF Center For Advanced Wound Care At
687
mi
from 98109
Daly City, CA
Click here to add this to my saved trials
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. Phase A: Breath Testing and Colonic Transit in Hepatic Encephalopathy. Phase B: A Randomized Double Blind, Placebo Controlled Trial of Rifaximin for Hepatic Encephalopathy
Status: Enrolling
Updated:  11/4/2010
New York Presbyterian Hospital: Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. Phase A: Breath Testing and Colonic Transit in Hepatic Encephalopathy. Phase B: A Randomized Double Blind, Placebo Controlled Trial of Rifaximin for Hepatic Encephalopathy
Status: Enrolling
Updated: 11/4/2010
New York Presbyterian Hospital: Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
The Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
Status: Enrolling
Updated:  11/4/2010
New York Presbyterial, Weill Cornell medical College
2402
mi
from 98109
New York, NY
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
The Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
Status: Enrolling
Updated: 11/4/2010
New York Presbyterial, Weill Cornell medical College
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials